Lifeboat Foundation

Two recent studies due to be presented as posters at the American Heart Association (AHA) Scientific Sessions 2023 between November 11–13 examine how frequent cannabis use could potentially lead to increased chances of cardiology issues, including heart attack, stroke, or heart failure. These studies were conducted by an international team of researchers and holds the potential to help scientists, medical professionals, and the public better understand the long-term health risks associated with cannabis use, specifically pertaining to cardiovascular concerns.

For the first study, which was conducted by the All of Us Research Program, researchers enlisted 156,999 participants who had not experienced heart failure at the time of the study’s enrollment to take part in a survey-based study to evaluate their cannabis use habits and conduct a follow-up survey 45 months later. The results indicated that heart failure emerged with 2,958 (1.88 percent) of the participants during the 48-month study period along with a 34 percent increased risk of emerging heart failure for participants were reported daily cannabis use compared to participants who didn’t use cannabis.

“Our results should encourage more researchers to study the use of marijuana to better understand its health implications, especially on cardiovascular risk,” said Dr. Yakubu Bene-Alhasan, who is a resident physician at Medstar Health and lead author of the study. “We want to provide the population with high-quality information on marijuana use and to help inform policy decisions at the state level, to educate patients and to guide health care professionals.”

In June 2021, 46-year-old Aaron James of Arkansas miraculously survived a 7,200-volt electric shock.

NYU LANGONE STAFF

The surgical team at NYU Langone Health performed a complex 21-hour procedure to transplant an entire eye along with a part of the face for a military veteran who had experienced a life-altering accident.

This is not a networking terminology but quite literally the vegetable grown using 5G technology.

Telia.

5G is the latest generation of mobile telephony commercially available and has been touted as a game changer in various fields. This service’s use cases that provide high-speed internet with low latency extend from medicine to gaming and entertainment to manufacturing.

Current osteoarthritis treatment manages symptoms rather than addressing the underlying disease, but a new University of Adelaide study has shown the condition may be treatable and reversible.

Osteoarthritis is the degeneration of cartilage and other tissues in joints and is the most common form of arthritis in Australia, with one in five people over the age of 45 having the condition.

It is a long-term and progressive condition which affects people’s mobility and has historically had no cure. Its treatment cost the Australian health system an estimated $3.9 billion in 2019–20.

The eye transplant, which was combined with a partial face transplant, did not restore vision. Experts still say it is a groundbreaking achievement.

Researchers at the University of São Paulo (USP) in Brazil, partnering with colleagues in Australia, have identified a novel bacterial protein that can keep human cells healthy even when the cells have a heavy bacterial burden. The discovery could lead to new treatments for a wide array of diseases relating to mitochondrial dysfunction, such as cancer and auto-immune disorders. Mitochondria are organelles that supply most of the chemical energy needed to power cells’ biochemical reactions.

The study is published in the journal PNAS. The researchers analyzed more than 130 proteins released by Coxiella burnetii when this bacterium invades host cells, and found at least one to be capable of prolonging cell longevity by acting directly on mitochondria.

After invading host cells, C. burnetii releases a hitherto unknown protein, which the authors call mitochondrial coxiella effector F (MceF). MceF interacts with glutathione peroxidase 4 (GPX4), an anti-oxidant enzyme located in the mitochondria, to improve mitochondrial function by promoting an anti-oxidizing effect that averts cell damage and death, which may occur when pathogens replicate inside mammalian cells.

Bryan Johnson is the world’s most famous biohacker – and perhaps the “most measured man in human history”. He’s on a mission to maximally reverse the quantified biological age of each of his 70 organs, extending his lifespan and healthspan, and then roll out his protocol on a platform to ensure others can benefit from his experience, research and experimentation.

Johnson’s ethos can be summed up pretty neatly as don’t die, and to that end, he has written a book, or novel, to be more accurate, entitled Don’t Die, the uncorrected advanced reading version of which is downloadable as a free ebook from his website. Johnson’s nom de plume for this venture is Zero, described in the book as the “first individual H. sapiens to surpass five hundred years of age,” who dies in 2,478 (in an accident, rather than from old age), just weeks away from “becoming Homo Deus.” Johnson credits Zero with the invention of Zeroism and the resurrection technology undie, as well as the fathering of “millions of biological and digital offspring who now live in the far reaches of the solar system and beyond”

Longevity. Technology: Because Don’t Die is a novel, Johnson can explore his philosophy in a different way, inviting us to observe the narrator, Scribe, on his last day on Earth, as he muses on humanity’s future evolution, the nature of death and free will and the impact of age reversal and programmable biology. Scribe is joined by a Pilgrim’s Progress-like cast of characters, including Cognitive Bias, Dark Humor and Game Play and Self Critical.

Fellow Macquarie University researchers Dr Ram Maharjan and Associate Professor Amy Cain are part of a contingent of scientists coming at the issue from another direction: studying a single protein that, when damaged, causes A. baumannii to lose its superpowers, compromising a drug pumping system that pushes antibiotics and other threats out of the cell.

While further studies are needed to understand how biocides work and how they interact with antibiotics, Dr Li stressed we should not discontinue their use in healthcare facilities and in the community.

“The findings in our study suggest that residual biocides could compromise antibiotic potency, at least in the lab,” Dr Li said.

Insulin pills designed to be dissolved in the mouth appear to overcome a major hurdle holding back the development of oral insulin.